180,183 Shares in Privia Health Group, Inc. $PRVA Acquired by Great Lakes Advisors LLC

Great Lakes Advisors LLC purchased a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 180,183 shares of the company’s stock, valued at approximately $4,487,000. Great Lakes Advisors LLC owned approximately 0.15% of Privia Health Group at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. CWM LLC raised its position in Privia Health Group by 89.4% during the 2nd quarter. CWM LLC now owns 3,416 shares of the company’s stock worth $79,000 after buying an additional 1,612 shares during the last quarter. Canada Pension Plan Investment Board grew its holdings in Privia Health Group by 48.0% in the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after purchasing an additional 1,200 shares during the period. Raymond James Financial Inc. acquired a new stake in Privia Health Group in the 2nd quarter valued at $113,000. Covestor Ltd grew its position in shares of Privia Health Group by 39.8% in the third quarter. Covestor Ltd now owns 5,824 shares of the company’s stock valued at $145,000 after purchasing an additional 1,657 shares during the period. Finally, Acadian Asset Management LLC acquired a new stake in Privia Health Group in the 1st quarter worth about $154,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Up 1.5%

Shares of NASDAQ PRVA opened at $23.22 on Friday. The business’s 50 day moving average is $23.83 and its two-hundred day moving average is $23.13. Privia Health Group, Inc. has a 52-week low of $18.77 and a 52-week high of $26.51. The firm has a market cap of $2.86 billion, a price-to-earnings ratio of 178.63, a PEG ratio of 1.61 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Thursday, November 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.23. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The firm had revenue of $580.42 million for the quarter, compared to the consensus estimate of $494.98 million. During the same period in the prior year, the firm earned $0.20 EPS. The firm’s revenue for the quarter was up 32.5% on a year-over-year basis. Analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Privia Health Group in a research report on Monday, December 29th. BMO Capital Markets started coverage on shares of Privia Health Group in a research note on Thursday, November 13th. They set an “outperform” rating and a $30.00 price objective for the company. Evercore ISI increased their price objective on shares of Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a report on Friday, November 7th. Stephens reissued an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a research note on Thursday, December 4th. Finally, Barclays boosted their target price on Privia Health Group from $22.00 to $23.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $30.50.

Insider Buying and Selling

In other Privia Health Group news, Director Matthew Shawn Morris sold 13,647 shares of the company’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $25.01, for a total value of $341,311.47. Following the completion of the transaction, the director owned 68,188 shares in the company, valued at $1,705,381.88. This represents a 16.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO David Mountcastle sold 23,887 shares of the stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $25.03, for a total value of $597,891.61. Following the completion of the sale, the chief financial officer directly owned 172,909 shares of the company’s stock, valued at $4,327,912.27. The trade was a 12.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 10.70% of the stock is currently owned by company insiders.

Privia Health Group Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.